SEC Comment Letter 0000000000-23-007464 to ImmunoPrecise Antibodies Ltd. (IPA) (CIK 0001715925) (HYFT)
ImmunoPrecise Antibodies Ltd. (IPA) (CIK 0001715925)
Date: July 12, 2023 · CIK: 0001715925 · Accession: 0000000000-23-007464
AI Filing Summary & Sentiment
File numbers found in text: 333-273197
Letter
United States securities and exchange commission logo July 12, 2023 Jennifer Bath Chief Executive Officer ImmunoPrecise Antibodies Ltd. 4837 Amber Valley Parkway Suite 11 Fargo, ND 58104 Re:ImmunoPrecise Antibodies Ltd. Registration Statement on Form F-3 Filed July 11, 2023 File No. 333-273197 Dear Jennifer Bath: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: James Guttman, Esq.
Show Raw Text
United States securities and exchange commission logo
July 12, 2023
Jennifer Bath
Chief Executive Officer
ImmunoPrecise Antibodies Ltd.
4837 Amber Valley Parkway Suite 11
Fargo, ND 58104
Re:ImmunoPrecise Antibodies Ltd.
Registration Statement on Form F-3
Filed July 11, 2023
File No. 333-273197
Dear Jennifer Bath:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: James Guttman, Esq.